Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: Sr K who wrote (752)	12/6/2000 10:43:40 PM
From: Sr K	Respond to of 756

A portion of the 12/06/2000 release: The company further announced that, as of November 30th, it had repurchased 1,047,800 shares of its common stock, at an average price of $33.75, under a 10 million share repurchase program authorized by the IVAX Board of Directors in August 2000. Under this same program, IVAX sold 1.0 million put options, of which 0.5 million have expired and the remainder will expire in February 2001. As of November 30th, IVAX had approximately 159.2 million common shares outstanding.